Preimplantation Genetic Testing in Women of Advanced Maternal Age

Trial ID or NCT#

NCT04167748

Status

recruiting iconRECRUITING

Purpose

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Official Title

GEnetic Testing in Elective Single Embryo Transfer in Women of Advanced Maternal Age

Eligibility Criteria

Ages Eligible for Study: 35 to 40
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Women undergoing IVF of between 35 and 40 years of age at IVF cycle start* Utilization of Intracytoplasmic Sperm Injection ICSI* Utilization of ejaculated or testicular sperm* Utilization of autologous or donor sperm* All Controlled Ovarian Hyperstimulation (COH) protocols
Exclusion Criteria:
  1. * Patients with anovulatory Polycystic ovarian syndrome (PCOS)* Utilization of donor oocytes* Utilization of gestational carrier* Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages* Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers
View All Criteria
Show Less

Contact us to find out if this trial is right for you.

Contact

Ruth B Lathi, MD
6504987911

SEND MESSAGE

View on ClinicalTrials.gov